Drug-like Antagonists of P2Y Receptor Subtypes: An Update

Area of Science:

• Pharmacology
• Medicinal Chemistry
• Drug Discovery

Background:

• P2Y receptors (P2YRs) play crucial roles in various physiological processes, including platelet aggregation, cancer, pain, neurodegeneration, and immune responses.
• Despite extensive research, only a few small-molecule antagonists for the P2Y12 receptor are clinically approved, necessitating further drug development.
• The discovery of crystal structures and advancements in screening methods have revitalized the search for P2YR modulators.

Purpose of the Study:

• To critically review P2Y receptor antagonists published since 2016.
• To identify potential oral lead- or drug-like compounds for clinical evaluation.
• To provide insights into the current landscape of P2YR antagonist research.

Main Methods:

• Literature review of P2Y receptor antagonists published from 2016 onwards.
• Analysis of small-molecule antagonists, including orthosteric and allosteric modulators.
• Consideration of compounds with potential for oral administration and clinical development.

Main Results:

• Identification of several promising small-molecule P2YR antagonists.
• Highlighting compounds with drug-like properties suitable for further development.
• Assessment of recent advancements in P2YR antagonist research, including structural biology and screening technologies.

Conclusions:

• The field of P2YR antagonists is dynamic, with significant progress in identifying novel compounds.
• Several orally available P2YR antagonists show promise for clinical translation.
• Continued research into P2YR modulators is essential for addressing unmet medical needs in various diseases.